MOTUS GI (@motus_gi) 's Twitter Profile
MOTUS GI

@motus_gi

Motus GI (NASDAQ: MOTS) is dedicated to improving colonoscopy outcomes and experiences through the development and commercialization of the Pure-Vu® System

ID: 793480431379382272

linkhttp://www.motusgi.com calendar_today01-11-2016 15:50:52

441 Tweet

1,1K Followers

580 Following

MOTUS GI (@motus_gi) 's Twitter Profile Photo

Dr. Brian Hanson discusses the Poor Prep Problem and how Pure-Vu EVS has helped improve visualization from a baseline BBPS score of 4.2 to 8.6, allowing for all surveillance exams to be given the maximum follow-up interval. Watch the presentation here: youtube.com/watch?v=kJO3Ri…

Dr. Brian Hanson discusses the Poor Prep Problem and how Pure-Vu EVS has helped improve visualization from a baseline BBPS score of 4.2 to 8.6, allowing for all surveillance exams to be given the maximum follow-up interval. Watch the presentation here: youtube.com/watch?v=kJO3Ri…
MOTUS GI (@motus_gi) 's Twitter Profile Photo

Pre-clinical tests show enhanced functionality of Pure-Vu EVS that can enable physicians to overcome common visualization challenges encountered during emergency upper GI bleeding procedures lnkd.in/eER2awAJ #EGD #UpperGIbleed #Visualizationwhenitmattersmost $MOTS

Pre-clinical tests show enhanced functionality of Pure-Vu EVS that can enable physicians to overcome common visualization challenges encountered during emergency upper GI bleeding procedures lnkd.in/eER2awAJ
#EGD #UpperGIbleed #Visualizationwhenitmattersmost $MOTS
MOTUS GI (@motus_gi) 's Twitter Profile Photo

This recent multicenter, cross-sectional, retrospective study, analyzed 260,314 colonoscopies and found that ONLY 31.9% of patients were recommended for follow-up within 1 year for repeat colonoscopy after inadequate bowel preparation; outside of published guidelines.

This recent multicenter, cross-sectional, retrospective study, analyzed 260,314 colonoscopies and found that ONLY 31.9% of patients were recommended for follow-up within 1 year for repeat colonoscopy after inadequate bowel preparation; outside of published guidelines.
MOTUS GI (@motus_gi) 's Twitter Profile Photo

MotusGI Board of Directors approved restructuring program with the objective of preserving capital to align with strategic process timeline. lnkd.in/eB-fUDhm $MOTS

MotusGI Board of Directors approved restructuring program with the objective of preserving capital to align with strategic process timeline. lnkd.in/eB-fUDhm
$MOTS
MOTUS GI (@motus_gi) 's Twitter Profile Photo

Our recent lab performing #EGD using the Pure-Vu System on a poorly-prepared colon resulted in all physician participants noting potential for dramatic improvement in patient care with Pure-Vu. Thanks Drs. Hanson, Goodman, Shaukat, Bilal, Latorre, and Barkin for your support!

Our recent lab performing #EGD using the Pure-Vu System on a poorly-prepared colon resulted in all physician participants noting potential for dramatic improvement in patient care with Pure-Vu. Thanks Drs. Hanson, Goodman, Shaukat, Bilal, Latorre, and Barkin for your support!
MOTUS GI (@motus_gi) 's Twitter Profile Photo

We’re pleased to announce regulatory clearance for the Pure-Vu EVS System in Israel, a leading market in the region. Already cleared by the U.S. FDA, the system is designed to provide better-quality #Colonoscopy exams. Explore Pure-Vu's potential: motusgi.com/news-media/new…

We’re pleased to announce regulatory clearance for the Pure-Vu EVS System in Israel, a leading market in the region. Already cleared by the U.S. FDA, the system is designed to provide better-quality #Colonoscopy exams. Explore Pure-Vu's potential: motusgi.com/news-media/new…
MOTUS GI (@motus_gi) 's Twitter Profile Photo

We're excited to announce the appointment of Scott Durbin to the Motus GI Board of Directors! With 25+ years of leadership, finance and #ClinicalDevelopment experience, we're confident he will bring immense value to our Board. More about Scott here: motusgi.com/news-media/new…

We're excited to announce the appointment of Scott Durbin to the Motus GI Board of Directors! With 25+ years of leadership, finance and #ClinicalDevelopment experience, we're confident he will bring immense value to our Board. More about Scott here: motusgi.com/news-media/new…
MOTUS GI (@motus_gi) 's Twitter Profile Photo

Using the Pure-Vu EVS system could be a game-changer for #endoscopy procedures. Read Tessa Herman’s evaluation of how Pure-Vu could positively impact the adequacy of #bowelprep via Gastroenterology & Endoscopy News: gastroendonews.com/Endoscopy-Suit…

MOTUS GI (@motus_gi) 's Twitter Profile Photo

We recently flew to Ecuador for clinical work at the Pentax training center, led by Dr. Robles. Over 3 days, we completed 14 cases in both the #colon and #UpperGI tract, with great feedback on the Pure-Vu EVS system! Our mission is to provide better-quality #endoscopy procedures.

We recently flew to Ecuador for clinical work at the Pentax training center, led by Dr. Robles. Over 3 days, we completed 14 cases in both the #colon and #UpperGI tract, with great feedback on the Pure-Vu EVS system! Our mission is to provide better-quality #endoscopy procedures.
MOTUS GI (@motus_gi) 's Twitter Profile Photo

We’re excited to share that we've submitted a special 510k to the FDA for market clearance of our new technology for GI. We’re confident the platform’s capabilities in supporting #UpperGI procedures will help address an area of high unmet patient need. motusgi.com/news-media/new…

We’re excited to share that we've submitted a special 510k to the FDA for market clearance of our new technology for GI. We’re confident the platform’s capabilities in supporting #UpperGI procedures will help address an area of high unmet patient need. motusgi.com/news-media/new…
MOTUS GI (@motus_gi) 's Twitter Profile Photo

Motus GI’s DNA is deeply intertwined with Israel and we are horrified by the recent events that have devastated generations of innocent civilians. Israel, we stand with you. We will overcome this.

MOTUS GI (@motus_gi) 's Twitter Profile Photo

We are thrilled to announce that we have received FDA clearance to commercialize Pure-Vu EVS Gastro and Gen 4 Colon. ✅ This streamlined, simple approach will allow physicians to provide urgent care for those with #GI bleeds. Read the release: brnw.ch/21wDOYS

We are thrilled to announce that we have received FDA clearance to commercialize Pure-Vu EVS Gastro and Gen 4 Colon. ✅ This streamlined, simple approach will allow physicians to provide urgent care for those with #GI bleeds. Read the release: brnw.ch/21wDOYS
MOTUS GI (@motus_gi) 's Twitter Profile Photo

We have completed a successful FDA inspection at our headquarters in Florida. A special thank you to Ravit Ram (CFO) and Raanan Cohen (Sr. Director of QA) for supporting the inspection. Our hard-working leadership is dedicated to ensuring the highest quality of systems.

We have completed a successful FDA inspection at our headquarters in Florida. A special thank you to Ravit Ram (CFO) and Raanan Cohen (Sr. Director of QA) for supporting the inspection. Our hard-working leadership is dedicated to ensuring the highest quality of systems.
MOTUS GI (@motus_gi) 's Twitter Profile Photo

The first #UpperGIpatient procedure with our Pure-Vu EVS Gastro device has been completed at the Minneapolis VA Health Care System. We look forward to implementing the planned U.S. market introduction of the device and are encouraged by these results. brnw.ch/21wElBN

The first #UpperGIpatient procedure with our Pure-Vu EVS Gastro device has been completed at the <a href="/VAMinneapolis/">Minneapolis VA Health Care System</a>. We look forward to implementing the planned U.S. market introduction of the device and are encouraged by these results. brnw.ch/21wElBN
MOTUS GI (@motus_gi) 's Twitter Profile Photo

Here at Motus GI, we are thankful for the opportunity to improve the lives of patients, providers, and people. 🌎 We could not do what we do without the support of the people who believe in our technology and the benefit it can provide to patients. Thank you!

MOTUS GI (@motus_gi) 's Twitter Profile Photo

Our lead product is a game-changer. 🎉 The success of Pure-Vu EVS gives a positive outlook for #UpperGI procedures for physicians and patients alike, especially in emergent situations like a GI bleed. Learn more about the Pure-Vu EVS System: brnw.ch/21wFd70

Our lead product is a game-changer. 🎉 The success of Pure-Vu EVS gives a positive outlook for #UpperGI procedures for physicians and patients alike, especially in emergent situations like a GI bleed. Learn more about the Pure-Vu EVS System: brnw.ch/21wFd70
MOTUS GI (@motus_gi) 's Twitter Profile Photo

With recent FDA clearance of the Gastro version of our Pure-Vu EVS device, it is gaining praise from the medical community. Thank you, Dr. Hanson and the team at Minneapolis VA Health Care System for your recognition. We look forward to seeing how Pure-Vu shapes the treatment of #UpperGI bleeds.

MOTUS GI (@motus_gi) 's Twitter Profile Photo

We're happy to report a successful ISO & EU MDR audit with no findings, signifying our commitment to quality. Thank you to our dedicated team for their crucial role in advancing our product toward commercialization in the EU.

MOTUS GI (@motus_gi) 's Twitter Profile Photo

We are excited to announce positive results from a European study published in the UEGJ of the Second Generation Pure-Vu System in improving visualization for #colonoscopy in patients with a history of poor #bowelprep. motusgi.com/news-media/new…

We are excited to announce positive results from a European study published in the <a href="/UEGJournal/">UEGJ</a> of the Second Generation Pure-Vu System in improving visualization for #colonoscopy in patients with a history of poor #bowelprep. motusgi.com/news-media/new…
MOTUS GI (@motus_gi) 's Twitter Profile Photo

Happy to share that @shravreddymd completed the first procedure at UCI Health with our new device; thanks to Dr. Jason Samareasena's advocacy for the program. The staff and physician reported ease-of-use and device functionality that supports a #GI bleed case.

Happy to share that @shravreddymd completed the first procedure at <a href="/UCIrvineHealth/">UCI Health</a> with our new device; thanks to Dr. Jason Samareasena's advocacy for the program. The staff and physician reported ease-of-use and device functionality that supports a #GI bleed case.